据彭博新闻社报道,诺华接近以每股 70 多美元的价格收购 Avidity 生物科学公司

路透中文
Oct 26, 2025
据彭博新闻社报道,<a href="https://laohu8.com/S/NVS">诺华</a>接近以每股 70 多美元的价格收购 Avidity <a href="https://laohu8.com/S/000504">生物</a>科学公司

路透10月26日 - 据彭博新闻社周日援引一位熟悉内情的人士的话报道,瑞士制药商诺华公司NOVN.S即将以每股超过70美元的价格收购美国生物技术公司Avidity BiosciencesRNA.O

路透无法立即证实这一报道。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10